ReviewTherapeutic advances in respiratory disease

Doxycycline treatment of high-risk COVID-19-positive patients with comorbid pulmonary disease.

Paul A Yates et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.